kala-azar presentation

25
VL Kenya. Leishmaniasis Overview. 15 th August 2008 Dr. James Teprey. WHO.

Upload: ochakenya

Post on 12-Nov-2014

1.839 views

Category:

Documents


2 download

DESCRIPTION

Kala-Azar Presentation

TRANSCRIPT

Page 1: Kala-Azar Presentation

VL Kenya.Leishmaniasis Overview.

15th August 2008

Dr. James Teprey. WHO.

Page 2: Kala-Azar Presentation

General Over view of the Leishmaniasis Present in 88 countries. More prevalence

for VL in Bangladesh, India, Nepal, Brazil and Horn of Africa (Sudan, Ethiopia, Kenya, Uganda, Somalia)

2 million new cases / year; 500.000 from VL, probably under-reported cases.

Global mortality estimated 59.000/yr. WHA resolution 2007: call State Members

to support Leishmaniasis

Page 3: Kala-Azar Presentation
Page 4: Kala-Azar Presentation

International Leadership in NTD

Page 5: Kala-Azar Presentation

Parasite: Leishmania donovani

Transmission: mainly anthroponotic

Vector: Phlebotomus martini. (Ph. Orientalis –Ethiopia)

Habitat: dry savannah, Acacia thorn bushes,

Balanites trees, craks of mud-covered dwellings, cow dung, rat burrows, anthills, termite hills...

Visceral Leishmaniasis (Kala-azar) in Kenya

Page 6: Kala-Azar Presentation
Page 7: Kala-Azar Presentation
Page 8: Kala-Azar Presentation
Page 9: Kala-Azar Presentation

Active CasesSporadic

Cases

Page 10: Kala-Azar Presentation

Vector Disease is transmitted by sand fly (Phlebotomus)

Page 11: Kala-Azar Presentation

Vector

o Sand fly – Phlebotomus (70 especies) - females

o Transmitting period – before the main rainy season

o Different biting patterns (outdoors during the night, from sunset to sunrise, indoors or peri-domestic)

Page 12: Kala-Azar Presentation

08/04/23 12

Epi-CurveEpi-Curve

Epi-Curve of VL Cases in Wajir/ Isiolo Outbreak 2008

01

23

456

78

910

Date of Health Facility Visit

No. of C

ases

No of Cases

Page 13: Kala-Azar Presentation

08/04/23 13

Distribution of VL Cases by GenderDistribution of VL Cases by Gender

Distribution of VL Cases by Gender

Males

Females

Males 60% and Females 40%

Page 14: Kala-Azar Presentation

08/04/23 14

Distribution of VL Cases by AgeDistribution of VL Cases by Age

Age Distribution of VL Cases in Wajir/ Isiolo Outbreak in 2008

0

20

40

60

80

< 1 yr 1 - 4 Yrs 5 - 14 Yrs 15+ YrsAge-groups

Case

s

Page 15: Kala-Azar Presentation
Page 16: Kala-Azar Presentation

Reservoir

o Humans – especially PKDL patientso Animals – dogs ( mainly Europe), fox, rats, jackals……

o Most commonly KA is spread human to human, however transmission from animal to human is possible but less common (Sudan)

o Others: congenital, needles (drug abuse), blood transfusion, sexual, bites from infected animal

Page 17: Kala-Azar Presentation

Prevention. Vector control: indoor residual spraying and use

of ITN Control of reservoir hosts: as antroponotic

transmission, early diagnosis and treatment is the most efective (decentralise diagnosis and support treatment centres). Treat PKDL

Individual protection measures: plastering of breeding places, avoid outdoor activities from dusk to down, wear socks, long trousers.

Health Education/Promotion PKDL treatment Surveillance and outbreak response.

Page 18: Kala-Azar Presentation

Clinical pictures

o Cutaneous Leishmaniasis - CL

o Muco Cutaneous Leishmaniasis - MCL

o Visceral Leishmaniasis -VL- kala-azar (KA)

o Post kala-azar dermatitis PKDL

Page 19: Kala-Azar Presentation
Page 20: Kala-Azar Presentation
Page 21: Kala-Azar Presentation
Page 22: Kala-Azar Presentation
Page 23: Kala-Azar Presentation
Page 24: Kala-Azar Presentation

Differential diagnosis

Chronic malaria (TSS): usually long standing disease (do B/F if one considers acute malarial attack)

Shistosomiasis: chronic course, signs of portal hypertension ,epidemiology of the disease (exposure history) and no fever

Typhoid fever: acute / sub acute, severe headache, change of mental status (typhoid psychosis) as time goes on.

Page 25: Kala-Azar Presentation

Differential diagnosis

Tuberculosis: usually significant respiratory symptoms and signs; splenomegaly is rare unless milliary form.

Hematological malignancies (leukemia's): possible, but are rare.